Reported 1 day ago
Vertex Pharmaceuticals Incorporated has launched JOURNAVX, a groundbreaking non-opioid medication designed to treat moderate-to-severe acute pain. This innovative treatment, recognized as a 2025 Breakthroughs Innovation Celebration winner, addresses pain pathways directly without the addiction risks associated with opioids. The launch aligns with broader public health initiatives aimed at reducing opioid dependency, marking a significant advancement in pain management.
Source: YAHOO